Wild-type p53 inhibits pro-invasive properties of TGF-ß3 in breast cancer, in part through regulation of EPHB2, a new TGF-ß target gene.

Lam, Suzanne; Wiercinska, Eliza; Teunisse, Amina F A S; Lodder, Kirsten; ten Dijke, Peter; Jochemsen, Aart G

Lam, Suzanne; Wiercinska, Eliza; Teunisse, Amina F A S; Lodder, Kirsten; ten Dijke, Peter; Jochemsen, Aart G.

Affiliation

Lam S; Department of Molecular Cell Biology, Cancer Genomics Centre Netherlands, Leiden University Medical Center, P.O. Box 9600, 2300 RC, Leiden, The Netherlands, suus.lam@gmail.com.

Breast Cancer Res Treat ; 148(1): 7-18, 2014 Nov.

Article in En | MEDLINE | ID: mdl-25257729

Subject(s)

Breast Neoplasms/genetics; Neoplasm Invasiveness/genetics; Receptor, EphB2/genetics; Transforming Growth Factor beta3/genetics; Tumor Suppressor Protein p53/genetics; Breast Neoplasms/pathology; Cell Line, Tumor; Cell Movement/genetics; Epithelial-Mesenchymal Transition/genetics; Gene Expression Regulation, Neoplastic/genetics; Humans; Transfection

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Tumor Suppressor Protein p53 / Receptor, EphB2 / Transforming Growth Factor beta3 / Neoplasm Invasiveness Type of study: Prognostic_studies Limits: Humans Language: En Journal: Breast Cancer Res Treat Year: 2014 Type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google